Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.17 USD | -3.97% | -9.83% | +2.29% |
May. 13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
May. 10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
Business Summary
Number of employees: 33
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 05-12-31 |
James Mackaness
DFI | Director of Finance/CFO | 60 | 19-11-13 |
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Kristen Yen
CTO | Chief Tech/Sci/R&D Officer | 55 | 05-12-31 |
Charles Horn
PRN | Corporate Officer/Principal | - | 21-12-31 |
Corporate Officer/Principal | - | Jan. 23 | |
Lauren Budesheim
HRO | Human Resources Officer | - | Jan. 23 |
Patricia Hirano
LAW | General Counsel | 58 | 17-03-31 |
Neil M. Cowen
PRN | Corporate Officer/Principal | - | 17-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 19-04-25 |
Bill Harris
BRD | Director/Board Member | 65 | 14-06-01 |
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 05-12-31 |
Andrew Sinclair
BRD | Director/Board Member | 52 | 18-12-20 |
Birgitte Volck
BRD | Director/Board Member | 61 | 19-06-09 |
Matthew Pauls
BRD | Director/Board Member | 53 | 23-08-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 34,678,159 | 31,162,511 ( 89.86 %) | 0 | 89.86 % |
Company contact information
Soleno Therapeutics, Inc.
203 Redwood Shores Parkway Suite 500
94065, Redwood City
+650 213 8444
http://www.soleno.lifeSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.22% | 1.56B | |
+10.58% | 115B | |
+12.74% | 106B | |
-4.61% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-11.05% | 17.56B | |
-39.36% | 17.32B | |
+6.81% | 14.03B | |
+32.64% | 12.13B |
- Stock Market
- Equities
- SLNO Stock
- Company Soleno Therapeutics, Inc.